Rein Therapeutics, Inc. Other Current Assets
Rein Therapeutics, Inc. (RNTX) had Other Current Assets of $727.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:OtherAssetsCurrent · last filed 2026-08-14
- 2026-06-30: Other Assets, Current $727.00K.
- 2026-03-31: Other Assets, Current $918.00K.
- 2025-12-31: Other Assets, Current $881.00K.
- 2025-09-30: Other Assets, Current $997.00K.
| Period end | Other Assets, Current |
|---|---|
| 2026-06-30 | $727.00K 10-Q · filed 2026-08-14 |
| 2026-03-31 | $918.00K 10-Q · filed 2026-05-15 |
| 2025-12-31 | $881.00K 10-Q · filed 2026-08-14 |
| 2025-09-30 | $997.00K 10-Q · filed 2025-11-14 |
| 2025-06-30 | $692.00K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $864.00K 10-Q · filed 2025-05-15 |
| 2024-12-31 | $676.00K 10-K · filed 2026-03-26 |
| 2024-09-30 | $755.00K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $304.00K 10-Q · filed 2024-08-14 |
| 2024-03-31 | $547.00K 10-Q · filed 2024-05-15 |
| 2023-12-31 | $675.00K 10-K · filed 2025-04-07 |
| 2022-12-31 | $606.00K 10-K · filed 2024-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |